Loading company…
OpGen develops molecular diagnostics focused on drug-resistant infections.
OpGen develops molecular diagnostic solutions for detecting drug-resistant infections, with products used by hospitals and clinical laboratories. Founded in 2002, the company is based in Rockville, US. In May 2015, it raised USD 11.99 mn through a Private Placement/Follow on.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in